Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease

被引:97
作者
Folwaczny, M
Glas, J
Török, HP
Limbersky, O
Folwaczny, C
机构
[1] Univ Munich, Poliklin Zahnerhaltung & Parodontol, Dept Operat Dent & Periodontol, D-80336 Munich, Germany
[2] Univ Munich, Med Klin, D-80336 Munich, Germany
[3] Univ Munich, Med Poliklin, D-80336 Munich, Germany
关键词
periodontitis; TLR2; TLR4; receptor; pathogen-associated molecular patterns (PAMPs); lipopolysaccharide; proinflammatory;
D O I
10.1111/j.1365-2249.2004.02383.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLR) are signal molecules essential for the cellular response to bacterial cell wall components. Different functional effective polymorphisms for the TLR 4 gene (Asp299Gly; Thr399Ile) and for the TLR 2 gene (Arg677Trp, Arg753Gln) have recently been described that are associated with impaired lipopolysaccharide signal transduction. A total of 122 patients with chronic periodontal disease and 122 healthy unrelated controls were genotyped for the Asp299Gly and Thr399Ile polymorphism of the TLR 4 gene and the Arg677Trp and Arg753Gln mutation of the TLR 2 gene. The mutations were identified with polymerase chain reaction followed by restriction fragment length polymorphism (RFLP) analysis. The prevalence of the Asp299Gly and the Thr399Ile mutant allele was 4.1% (10/244) and 4.5% (11/244) among periodontitis patients. For the healthy controls the prevalence was 3.3% (8/244) for the Asp299Gly (P = 0.810) and 3.7% (9/244) for the Thr399Ile mutant allele (P = 0.819). The Arg753Gln mutant allele was found in 2.9% (7/244) of the periodontitis subjects as compared to 4.1% (10/244) in the control group (P = 0.622). The Arg677Trp mutant allele was not found in any of the study subjects. Unlike in ulcerative colitis there was not observed an association between chronic periodontitis and the various mutations of the TLR 2 and 4 gene.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 25 条
[1]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[2]   Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections [J].
Agnese, DM ;
Calvano, JE ;
Hahm, SJ ;
Coyle, SM ;
Corbett, SA ;
Calvano, SE ;
Lowry, SF .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1522-1525
[3]   Toll-like receptors: critical proteins linking innate and acquired immunity [J].
Akira, S ;
Takeda, K ;
Kaisho, T .
NATURE IMMUNOLOGY, 2001, 2 (08) :675-680
[4]   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].
Arbour, NC ;
Lorenz, E ;
Schutte, BC ;
Zabner, J ;
Kline, JN ;
Jones, M ;
Frees, K ;
Watt, JL ;
Schwartz, DA .
NATURE GENETICS, 2000, 25 (02) :187-+
[5]   CD4+ T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice [J].
Baker, PJ ;
Dixon, M ;
Evans, RT ;
Dufour, L ;
Johnson, E ;
Roopenian, DC .
INFECTION AND IMMUNITY, 1999, 67 (06) :2804-2809
[6]   Cutting edge: A toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling [J].
Bochud, PY ;
Hawn, TR ;
Aderem, A .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3451-3454
[7]   Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling [J].
Erridge, C ;
Stewart, J ;
Poxton, IR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1787-1791
[8]   Periodontal disease: bacterial virulence factors, host response and impact on systemic health [J].
Graves, DT ;
Jiang, YL ;
Genco, C .
CURRENT OPINION IN INFECTIOUS DISEASES, 2000, 13 (03) :227-232
[9]   Phylogenetic perspectives in innate immunity [J].
Hoffmann, JA ;
Kafatos, FC ;
Janeway, CA ;
Ezekowitz, RAB .
SCIENCE, 1999, 284 (5418) :1313-1318
[10]   Toll-like receptor 4 polymorphisms and atherogenesis [J].
Kiechl, S ;
Lorenz, E ;
Reindl, M ;
Wiedermann, CJ ;
Oberhollenzer, F ;
Bonora, E ;
Willeit, J ;
Schwartz, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (03) :185-192